Newly-launched EUSA Pharma has named Lee Morley as its chief executive officer to manage the company’s specialty pharmaceuticals business in Europe. Mr Morley was previously head of commercial operations for Europe and international markets at Jazz Pharmaceuticals Plc, the previous owner of EUSA. In March 2015, EUSA Pharma was spun-out as an independent company with a portfolio of products for the hospital market.
EUSA has also appointed Göran Ando as a non-executive director. Dr Ando is chairman of Novo Nordisk A/S and a senior advisor to Essex Woodland, EUSA’s lead shareholder.
EUSA Pharma announced the appointments on 21 April 2015.
Copyright 2015 Evernow Publishing Ltd